Gold(iii) complexes inhibit growth of cisplatin-resistant ovarian cancer in association with upregulation of proapoptotic PMS2 gene

Water-Soluble Phosphanes Derived from 1,3,5-Triaza-7-phosphaadamantane and Their Reactivity towards Gold(I) Complexes

(2013) Elena García-Moreno et al.   EUROPEAN JOURNAL OF INORGANIC CHEMISTRY

Chemotherapy of MMR-deficient colorectal cancer

(2013) N. Devaud et al.   Familial Cancer

A gold(iii) porphyrin complex as an anti-cancer candidate to inhibit growth of cancer-stem cells

(2012) Ching Tung Lum et al.   CHEMICAL COMMUNICATIONS

Cytotoxic gold compounds: synthesis, biological characterization and investigation of their inhibition properties of the zinc finger protein PARP-1

(2012) Maria Serratrice et al.   DALTON TRANSACTIONS

Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds

(2012) Francesca Guidi et al.   Metallomics

Minimizing the damage: repair pathways keep mitochondrial DNA intact

(2012) Lawrence Kazak et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Syntheses, Characterizations, and a Preliminary Comparative Cytotoxicity Study of Gold(I) and Gold(III) Complexes Bearing Benzimidazole- and Pyrazole-Derived N-Heterocyclic Carbenes

(2012) Haresh Sivaram et al.   ORGANOMETALLICS

A spontaneous gold(i)-azide alkyne cycloaddition reaction yields gold-peptide bioconjugates which overcome cisplatin resistance in a p53-mutant cancer cell line

(2012) S. David Köster et al.   Chemical Science

Overcoming Temozolomide Resistance in Glioblastoma via Dual Inhibition of NAD+ Biosynthesis and Base Excision Repair

(2011) E. M. Goellner et al.   CANCER RESEARCH

Anticancer gold(i)–phosphine complexes as potent autophagy-inducing agents

(2011) Songhai Tian et al.   CHEMICAL COMMUNICATIONS

Therapeutic applications of gold complexes: lipophilic gold(iii) cations and gold(i) complexes for anti-cancer treatment

(2011) Chi-Ming Che et al.   CHEMICAL COMMUNICATIONS

Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: A systematic review

(2011) Mark Murphy et al.   DRUG RESISTANCE UPDATES

Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: Solution behavior, reactions with model proteins, antiproliferative properties

(2011) Laura Maiore et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Overcoming cisplatin resistance using gold(III) mimics: Anticancer activity of novel gold(III) polypyridyl complexes

(2011) Kamalakannan Palanichamy et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Histologic, Molecular, and Cytogenetic Features of Ovarian Cancers: Implications for Diagnosis and Treatment

(2011) Neeraj Lalwani et al.   RADIOGRAPHICS

Gold(III) porphyrin 1a prolongs the survival of melanoma-bearing mice and inhibits angiogenesis

(2010) Ching Tung Lum et al.   ACTA ONCOLOGICA

Gold(III) porphyrin 1a inhibited nasopharyngeal carcinoma metastasis in vivo and inhibited cell migration and invasion in vitro

(2010) Ching Tung Lum et al.   CANCER LETTERS

Gold(i) complex of N,N′-disubstituted cyclic thiourea with in vitro and in vivo anticancer properties—potent tight-binding inhibition of thioredoxin reductase

(2010) Kun Yan et al.   CHEMICAL COMMUNICATIONS

Cyclometalated gold(iii) complexes with N-heterocyclic carbene ligands as topoisomerase I poisons

(2010) Jessie Jing Yan et al.   CHEMICAL COMMUNICATIONS

Stable Anticancer Gold(III)-Porphyrin Complexes: Effects of Porphyrin Structure

(2010) Raymond Wai-Yin Sun et al.   CHEMISTRY-A EUROPEAN JOURNAL

Therapeutic Targeting of the DNA Mismatch Repair Pathway

(2010) S. A. Martin et al.   CLINICAL CANCER RESEARCH

Synthesis, characterisation and biological properties of gold(iii) compounds with modified bipyridine and bipyridylamine ligands

(2010) Angela Casini et al.   DALTON TRANSACTIONS

Gold(III)-dithiocarbamato anticancer agents: Activity, toxicology and histopathological studies in rodents

(2010) Cristina Marzano et al.   INTERNATIONAL JOURNAL OF CANCER

Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts

(2010) Lara Cattaruzza et al.   INTERNATIONAL JOURNAL OF CANCER

Inhibition of Akt sensitises neuroblastoma cells to gold(III) porphyrin 1a, a novel antitumour drug induced apoptosis and growth inhibition

(2009) W Li et al.   BRITISH JOURNAL OF CANCER

Gold (III) porphyrin complexes induce apoptosis and cell cycle arrest and inhibit tumor growth in colon cancer

(2009) Shuiping Tu et al.   CANCER

A Gold(III) Porphyrin Complex with Antitumor Properties Targets the Wnt/ -catenin Pathway

(2009) K. H.-M. Chow et al.   CANCER RESEARCH

On the medicinal chemistry of gold complexes as anticancer drugs

(2009) Ingo Ott   COORDINATION CHEMISTRY REVIEWS

Metal complexes in medicine with a focus on enzyme inhibition

(2009) Chi-Ming Che et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs

(2009) Sabine H. van Rijt et al.   DRUG DISCOVERY TODAY

Gold(III) porphyrin complex is more potent than cisplatin in inhibiting growth of nasopharyngeal carcinomain vitroandin vivo

(2008) Yuk Fai To et al.   INTERNATIONAL JOURNAL OF CANCER